Tech Company Financing Transactions
OWKIN Funding Round
Private investors invested in a $35.9 million funding round for OWKIN. The financing round was announced on 3/31/2023.
Transaction Overview
Company Name
Announced On
3/31/2023
Transaction Type
Venture Equity
Amount
$35,863,000
Round
Undisclosed
Investors
Proceeds Purpose
This project will make it possible to better fight cancer by equipping healthcare professionals with innovative artificial intelligence tools. The aim is to help doctors make the best use of the information contained in histological slides to personalise treatments. This ambitious project brings together major players in the field, both public and private, to form a community of internationally recognised and complementary experts. Nearly 15 million euros from France 2030 have been allocated to this project.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
831 Bdwy. 3R
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
OWKIN adresses the problem of low efficiency of pharma R&D in cancer and chronic diseases. Developing new integrative and interpretable technologies of machine learning, OWKINpharma main program harnesses pharmaceutical data such as chemical or clinical trials measurements.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/31/2023: Iteration X venture capital transaction
Next: 3/31/2023: PxE Holographic Imaging venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs